Side by side: size, value over time, results, valuation, margins, growth, debt and shareholder returns, and any of thirty figures charted over the years (up to 6).
Open these as a peer group: up to 12 companies with suggested peers, each company's rank in the group and percentile in its sector and country, saved for you or your team.
From Jan 2020: how each company's value moved, whatever its size.
US$ billions, as reported in each year's annual results.
Revenue of the fiscal year. US dollars at each year's exchange rate.
| Measure | Johnson & Johnson✕ JNJ · #23 in the world | Medcomtech, S.A.✕ MED.MC |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇪🇸 Spain |
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceutical | — |
| Founded | 1886 | — |
| Size | ||
| Market cap | ||
The largest companies, each against its nearest peers in value from the same industry.
| Fiscal year | Johnson & Johnson | Medcomtech, S.A. |
|---|---|---|
| 2025 | $94.2 BSEC | — |
| 2024 | $88.8 BSEC | — |
| 2023 | $85.2 BSEC | — |
| 2022 | $80.0 BSEC | — |
| 2021 | $78.7 BSEC | — |
| 2020 | $82.6 BSEC | — |
| 2019 | $82.1 BSEC | — |
| 2018 | $81.6 BSEC | — |
| 2017 | $76.5 BSEC | — |
| 2016 | $71.9 BSEC | — |
| 2015 | $70.1 BSEC | — |
| 2014 | $74.3 BSEC | — |
Sources: SEC = SEC annual reports (10-K, 20-F, 40-F); ESEF = ESEF annual reports; Ed. = the company's report (editors); WD = Wikidata, citing the annual report; Cap = value.today market caps. Hover a figure for its period.
| $652.5 B |
| $10 M* |
| Revenue | $94.2 B | — |
|---|
| Net income | $26.8 B | — |
|---|
| Employees | 138,200 | — |
|---|
| Valuation | ||
|---|---|---|
| P/E ratio | 40.5× | — |
| Price to sales | 6.6× | — |
| Price to book | 8.0× | — |
| Free cash flow yield | 3.0% | — |
| Altman Z-score zone | — | — |
|---|
| Data as of | Market cap Oct 2026 | Market cap Jan 2024 |
|---|
Market caps from exchange data or SEC filings on the date shown (* last known value, no current one); revenue and net income from the latest annual results; ratios worked out from each company's own statements for the fiscal year shown. ▲ marks the best of these companies where higher or lower is better; size and valuation multiples are marked for no one. Definitions: methodology.